Carbylan Therapeutics Inc. entered into a lease with BMR-Pacific Research Center LP for an 18,704 square foot facility at 7333-7999 Gateway Blvd. in Newark, CA. In addition to serving as the company’s headquarters, the office will include R&D and laboratory space.